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Abstract 
Riboswitches are gene regulatory elements found in the 5’ leader 
sequence of many bacterial genes. In a riboswitch, RNA directly binds ligand to 
affect transcription or translation of a downstream gene. Such a system could 
potentially be exploited in synthetic systems. However, one of the major hurdles 
for creating synthetic riboswitch regulatory systems (and other RNA devices) is 
creating RNA aptamers that are not only selected for binding, but also have 
potential for regulatory activity. In the present study, this problem was addressed, 
utilizing the tertiary architecture of a known purine-binding riboswitch and 
reselecting the binding pocket for 5-hydroxy-L-tryptophan (5HW) binding using in 
vitro selection. Three families arose in the selection. Two of the families had 
single nucleotide deletions that destroy the tertiary architecture of the purine 
riboswitch, but the third family maintained the primary sequence elements critical 
for forming the tertiary interactions between P2 and P3. The aptamer was 
crystallized and its structure was determined, revealing conservation of the loop-
loop interaction from the purine riboswitch, while the ligand-binding pocket was 
restructured to allow for 5HW binding. Ongoing research aims to determine the 
structure of a different family of aptamers that arose in the selection. Although 
this family does not resemble the original purine riboswitch, it does contain a 
previously characterized tryptophan aptamer that arose from a completely 
randomized selection. The aptamer is a small hairpin, so it was appended to the 
P3 and P4 helices of the SAM-I riboswitch to encourage crystallization. Currently, 
this SAM-I/tryptophan fusion RNA has been crystallized to a resolution of ~5.0 Å.  
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1. Introduction 
In order to efficiently function and reproduce, all organisms must be able 
to sense stimuli in their environment and react to these signals. Traditionally, it 
was thought that these reactions were mainly regulated by protein factors, which 
were believed to possess the structural and informational complexity required to 
bind specific metabolites or respond to other stimuli and appoint a suitable 
response. However, it has become apparent that RNA is also capable of 
regulating gene expression based on a number of environmental stimuli. 
Charles Yanofsky’s groundbreaking discovery of transcriptional 
attenuation was one of the first observed RNA gene regulation mechanisms 
(Figure 1). The mechanism was originally recognized in the trp operon, which 
	  
 
Figure 1: Transcriptional attenuation. A) In the presence of tryptophan, 
TRAP is activated and binds the nascent mRNA. The RNA wraps around the 
TRAP complex, preventing formation of the antiterminator stem and allowing 
for formation of the terminator stem. Transcription terminates. B) When 
tryptophan is not present, TRAP is not activated, and it does not bind the 
mRNA. The antiterminator is formed and the downstream gene is transcribed. 
Figure taken from Du et al., 2000. 
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controls tryptophan biosynthesis. A tryptophan RNA-binding attenuation protein 
(TRAP) was shown to control transcription based on intracellular tryptophan (Du 
et al., 2000). When TRAP is activated by high tryptophan concentrations, it binds 
the 5’ leader sequence of a nascent mRNA and promotes formation of a 
terminator stem, terminating transcription (Du et al., 2000). In contrast, when 
tryptophan concentrations are low, the TRAP is inactive, and an antiterminator 
stem is formed in the mRNA, allowing gene read-through (Du et al., 2000). 
Subsequently, it was discovered that RNA could directly bind a ligand and 
promote formation of the terminator or antiterminator stem without the need of a 
mediating attenuation protein. This new class of regulatory RNAs was collectively 
termed riboswitches (Winkler et al., 2002). Since their discovery, it has been 
demonstrated that over 4% of genes in Bacillus subtilis are controlled by 
riboswitches (Winkler and Breaker, 2005). Thus, for mechanisms that act after 
transcription has begun, RNA-dependent regulators are actually more frequent 
than protein-mediated regulation. 
 
1.1 The Transcriptional Control Mechanism 
Many riboswitch classes operate via the transcriptional control 
mechanism. These riboswitches can be divided into two distinct functional parts: 
the “aptamer,” or sensing domain, and the “expression platform,” or regulatory 
domain (Garst et al., 2009) As the riboswitch is transcribed, the aptamer domain 
can adopt one of two different conformations, dependent on the presence of its 
cognate metabolite. In an “OFF” switch, ligand binding stabilizes formation of the 
P1 helix, causing downstream formation of a terminator stem and aborting 
transcription. In the absence of ligand, an anti-terminator stem is formed, and the 
downstream gene is transcribed (Garst et al., 2009). “ON” switches have also 
been identified, where ligand binding allows read-through (Figure 2). 
The structural characteristics of all major classes of riboswitches have 
been analyzed, elucidating the mechanisms RNA employs to bind a metabolite 
with high affinity and specificity. This interaction can be monitored in vitro via 
isothermal titration calorimetry (ITC), which results in an apparent KD for ligand 
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binding. It can also be monitored 
in vitro using transcription 
assays that designate a T50, 
which is the concentration of 
ligand required to elicit half-
maximal response (Wickiser et 
al., 2005a). Additionally, in vivo 
assays have been developed 
which measure an EC50, the 
concentration of ligand required 
to elicit half-maximal response in 
vivo (Ceres et al., 2013).  
Aptamer domains can be 
categorized based on their 
secondary structures: type I, 
which encompasses 
riboswitches that bind their 
ligand in a multihelical junction, 
and type II, which are 
riboswitches that adopt an 
overall pseudoknot structure to bind the ligand (Serganov and Nudler, 2013). 
Type I riboswitches bind the ligand near the P1 stem and include including the 
thiamine pyrophospate (TPP) riboswitch (Edwards and Ferré-D’Amaré, 2006; 
Serganov et al., 2006; Thore et al., 2006), the lysine riboswitch (Garst et al., 
2008; Serganov et al., 2008), and the purine riboswitch (Batey et al., 2004; 
Serganov et al., 2004). Type I also includes the tetrahydrofolate (THF) 
riboswitch, which binds a second ligand far from the P1 stem (Trausch et al., 
2011). Representative type II riboswitches include the SAM II riboswitch (Gilbert 
et al., 2008) and the fluoride riboswitch (Ren et al., 2012). 
The purine riboswitch is a well-understood example of riboswitch structure 
(Gilbert et al., 2006). It displays several RNA structural elements that appear 
	  
Figure 2: Typical transcriptional riboswitch. 
In a typical transcriptional controlled riboswitch, 
in the presence of a metabolite (yellow), the 
switching sequence (SS) of the aptamer do 
main influences the formation of a Rho-
independent terminator stem followed by a 
poly-U tract, which forces the RNA polymerase 
(green) to abort transcription of a downstream 
gene. In the absence of ligand, an anti-
terminator stem is formed and read-through is 
permitted. Figure taken from Garst et al. 2009. 
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across riboswitch classes. One such element is coaxial stacking, apparent 
between the P1 and P3 helices, which creates a single pseudo-continuous helix 
(Garst et al., 2011). Additionally, the helices are arranged in a parallel 
conformation, which is apparent in most RNAs with three or more helices 
(Holbrook, 2008). The caps of the P2 and P3 helices, L2 and L3, are arranged in 
a kissing-loop motif (Gilbert et al., 2006).  
 
1.2 Alternative Regulatory Mechanisms 
In addition to the Rho-independent transcriptional control mechanism, 
riboswitches act in many alternative methods to elicit a regulatory response. 
Recently, Rho-dependent transcriptional control was observed in a Mg2+-sensing 
riboswitch (Hollands et al., 2012). This mechanism had previously been 
suggested through genomic analyses that predicted the presence of several 
riboswitches but lacked the primary sequence required to function as Rho-
independent transcriptional terminators (Irnov et al., 2010, Livny and Waldor, 
2010, Rhagavan et al., 2011).  
Additionally, many translationally controlled riboswitches have been 
identified (Lu et al., 2008, Rieder et al., 2007, Johnson et al., 2012). These 
riboswitches typically act through the sequestration of a ribosome binding 
sequence (RBS), preventing the ribosome to from initiating translation. 
Other mechanisms have been demonstrated in a select few riboswitches. 
Among these, the thymine pyrophosphate (TPP) riboswitch is the only riboswitch 
that has been identified in both eukaryotes and bacteria. Because eukaryotes 
have very different requirements for transcriptional and translational gene control, 
the TPP riboswitch is involved in alternate gene splicing mechanisms (Cheah et 
al, 2007; Wachter et al., 2007). In green algae, the TPP riboswitch creates a 
prematurely terminated peptide (Croft et al., 2007). In filamentous fungi, when 
ligand is bound, alternate splicing causes the mRNA to produce an aberrant 
peptide, which is then degraded by the cell (Cheah et al., 2007). The TPP 
riboswitch is also found in some higher plants, where alternative splicing causes 
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unstable long 3’ untranslated regions (Bocobza et al., 2007, Wachter et al., 
2007).  
 
1.3 Applications In Synthetic Biology 
Due to their ability to directly sense small molecules and affect a 
regulatory response without the need for additional mediating proteins, 
riboswitches are a particularly attractive target for creating novel gene-control 
elements. Synthetic biology is a growing field due to an increasing demand for 
renewable chemical synthesis mechanisms (Keasling, 2012). Naturally occurring 
enzyme pathways have been stitched together to create novel synthetic systems 
(Keasling, 2012), but such synthetic pathways may require optimization of 
transcription levels of each gene. For example, in designing a synthetic system 
for the synthesis of artemesinin (an anti-malarial drug) a natural mevalonate 
pathway was utilized, but enzyme levels were unbalanced, causing a buildup of 
HMG-CoA (Keasling, 2012). To alleviate this problem, mRNA secondary 
structures were designed to differentially stabilize mRNAs in the pathway and 
balance enzyme levels (Keasling, 2012). However, the design of a synthetic 
riboswitch could be an even more elegant mechanism to control gene expression 
levels. With a synthetic riboswitch, buildup of any intermediate could be 
monitored by a riboswitch that senses that product, and the enzyme that 
synthesizes that product could be downregulated, or the next enzyme in the 
pathway could be upregulated. 
To date, RNA engineering approaches have focused primarily on creating 
independent input or output domains. Output domains have been successfully 
created to induce fluorescent signal upon ligand binding using the malachite 
green aptamer (Stojanovic & Kolpashchikov, 2004). The fluorescent reporter 
domain of the RNA is fused to the ligand-sensing domain via a communication 
module composed of a short helix (Figure 3). Ligand binding increases the 
stability of the communication module, allowing the fluorescent reporter domain 
to fully form and bind the fluorescent ligand, increasing fluorescence (Stojanovic 
& Kolpashchikov, 2004). Additionally, synthetic gene-regulatory output domains 
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have been constructed by fusing aptamer domains to a non-native expression 
platform (Trausch et al., 2011, Ceres et al., 2013a). These chimeric riboswitches 
obey simple secondary-
structural principles that 
can easily be optimized 
to create a switch with 
the desired regulatory 
response to a particular 
metabolite concentration 
(Ceres et al., 2013a).  
However, these 
approaches have only 
proven broadly 
applicable for naturally 
occurring aptamer domains, which have been identified for a relatively small 
subset of cellular metabolites, let alone other molecules. RNA aptamers that bind 
any metabolite of interest can readily be selected using in vitro selection 
techniques (Ellington and Szostak, 1990). Some of these synthetic RNA 
aptamers have been fused to output domains to generate a response, but this 
approach has typically been slow, requiring tedious optimization (Ceres et al., 
2013, Berens et al., 2001). The caveat in this approach may be that in an in vitro 
selection, the aptamer is selected exclusively for its ability to bind a small 
molecule, whereas in a natural riboswitch, upon ligand binding, the aptamer 
domain must communicate to the expression platform and regulate transcription.  
The present study aimed to develop a novel riboswitch capable of binding 
a non-native ligand and regulating gene expression. To this end, the ligand-
binding pocket of the purine riboswitch was reselected for binding to a novel 
ligand, while distal residues were left intact. The tertiary structure of the purine 
riboswitch has been selected by nature to fold robustly and on a transcriptionally 
relevant timescale. By leaving the overall structure of the purine riboswitch 
undisturbed, it was hypothesized that the RNA could maintain regulatory abilities, 
	  
Figure 3: Malachite green fluorescent reporter. 
The malachite green aptamer is fused to an ATP-
binding aptamer via a communication module. 
Upon ATP binding, malachite green binding is 
promoted, and fluorescence increases. Figure 
adapted from (Stojanovic & Kolpashchikov, 2004). 
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even while binding a novel ligand. The purine riboswitch was reselected for 5-
hydroxy-L-tryptophan (5HW) binding via in vitro selection. A resulting aptamer 
sequence was crystallized, revealing remarkable structural conservation to the 
original purine riboswitch, while selectively binding 5HW. Current studies aim to 
crystallize a different aptamer sequence that resulted from the selection in order 
to better understand how different aptamers can bind the same ligand with 
different affinities and specificities. 
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2. Selection of a Novel Aptamer from an Existing Riboswitch Aptamer 
Domain 
The aptamer domain of a purine riboswitch was reselected for binding to 
5-hydroxy-L-tryptophan (5HW), a serotonin precursor. 5HW was chosen not only 
for its potential applications in the serotonin biosynthetic pathway, but also for the 
number of potential ways an RNA could recognize and bind it. 5HW has four 
functional groups that can form hydrogen bonds: the exocyclic 5-hydroxyl group, 
the endocyclic amine, and the amino and carboxyl groups. Additionally, the 
tryptophan ring system provides a good surface for pi-stacking interactions, 
which are often utilized in nucleic acid ligand recognition. 
 
2.1 Methods 
2.1.1 Library Preparation 
In order to alter ligand 
binding in the purine 
riboswitch, 23 residues 
located within 8 Å of the 
binding pocket were 
selected for randomization 
(Figure 4). Thus, the P1 
stem and the loop-loop 
interaction between P2 and 
P3 was left intact, while 
residues in the three-way 
junction binding site were 
randomized. Sequences 
were constructed with the aptamer domain flanked by non-variant SHAPE 
cassettes as described in Wilkinson et al., 2006. These SHAPE cassettes 
allowed for PCR amplification of the randomized library after each round of 
selection. Oligomer sequences are listed in supplemental information. The 
resulting library had 423 = 7 × 1013 unique sequences. During the selection, 200 
	  
Figure 4: Randomized regions of the purine 
riboswitch. Nucleotides within 8 Å of the ligand-
binding pocket (magenta) were randomized to create a 
starting library. Structure adapted from Gilbert et al., 
2009 (PDB ID: 3FO6). 
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pmol (1.2 × 1014 sequences) of RNA were present in the initial library. Thus, 
there was almost twofold redundancy of sequences in the initial library over 
unique sequences available in the selection. This ensured that every potential 
sequence was likely present in the initial pool, such that that no potential binders 
were omitted. This would not be possible in a selection with more randomized 
nucleotides. Furthermore, each sequence in the pool contained the information 
required to allow robust folding of the tertiary kissing loop from the purine 
riboswitch, creating a well-structured starting library. 
The library was tested for primer extension efficiency as described in 
Piasecki et al., 2009, and it was determined that the library extended with 10% 
efficiency. Thus, in order to ensure PCR amplification of every unique sequence, 
an initial PCR1 was performed with 10 µL of 37 µM randomized DNA template. 
The resulting DNA was used as the starting library for in vitro selection. 
The DNA was transcribed in vitro with T7 polymerase and purified in a 6, 
8, or 12% polyacrylamide denaturing gel. The RNA was then concentrated using 
Millipore 10,000 molecular weight cutoff (MWCO) concentrators and refolded by 
denaturing in 8 M urea and exchanging into a selection buffer containing 250 mM 
sodium chloride, 10 mM magnesium chloride, 50 mM potassium chloride, and 10 
mM HEPES pH 7.0. In addition, a 125 µL transcription was performed with 2 µL 
radiolabeled α-ATP, creating a smaller labeled RNA library. The radiolabeled 
library provided a marker to indicate the approximate amount of RNA washed off 
of the column versus the amount of RNA eluted. A smaller radiolabeled marker 
library was similarly created after each subsequent round of selection. 
 
2.1.2 In vitro Selection 
The following selection protocol was performed in parallel with my 
graduate student mentor, Ely Porter. This was done in order to demonstrate that 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Unless otherwise noted, all basic RNA preparation and purification techniques 
used throughout the thesis research (including polymerase chain reaction 
techniques, in vitro transcription techniques, and denaturing polyacrylamide gel 
electrophoresis) were performed as described in Edwards et al., 2009.	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two independent iterations of the same selection could result in the same RNA 
aptamer sequence. 
To select for 5HW binding, a column containing sepharose beads linked to 
the carboxyl terminus of 5HW was synthesized. Before the first and second 
rounds of selection, a counter-selection was performed against acetylated 
sepharose. During column synthesis, any beads unmodified by 5HW were 
capped with an acetyl group. Counter selection removed any sequences that 
preferentially bound the sepharose bead, the linker between the sepharose and 
the amino acid, or the uncapped end of a linker with an acetyl group.  
Five rounds of selection were performed, where 200 pmol of unlabeled 
RNA in 270 µL of selection buffer were added to 80 µL of radiolabeled RNA and 
loaded onto the equilibrated column. At the start of each round of selection, the 
RNA incubated at room temperature on the column for 45 minutes. RNA flow-
through was collected by centrifugation. The RNA was then washed 3 – 10 times 
(3 in round 1, 6 in round 2, and 10 each in rounds 3 – 5) with 350 µL of selection 
buffer. Two hour elutions were performed, collecting RNA two or four times (two 
times in rounds 1 – 3, and four times in rounds 4 and 5) over the course of the 
selection. 
An elution profile was created by blotting 10 µL of each flow-through, 
wash, and elutant in 
separate spots onto an 
electrostatic DEAE 
membrane. The amount of 
radiolabeled RNA in each 
spot was imaged with a 
Typhoon scanner and 
quantified using ImageJ, a 
free imaging program 
capable of integrating the 
density of each spot (Figure 
5). Dividing total elutant RNA by total RNA flow through for each round resulted 
	  
Figure 5: Quantification of selection rounds. 
Radiolabeled RNA is imaged and quantified after 
each round of selection. Total elutant (cyan) was 
summed and divided by total RNA. 
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in a measure of percent RNA elution. For example, in round 1, two elutions (E1 
and E2) and three washes (W1, W2, and W3) were performed, in addition to the 
column flow-through (FT): 
(E1 + E2) / (FT + W1 + W2 + W3 + E1 + E2) = Fraction elution 
At the end of each round, the elutant RNA was pooled and reverse 
transcribed to create a DNA library for the next round of selection. SuperScript III 
reverse transcriptase (RT) was obtained from Invitrogen and was utilized as 
described in protocols provided. The resultant ssDNA library was PCR amplified, 
transcribed, and purified as before and subjected to subsequent rounds of 
selection (Figure 6). 
 
	  
Figure 6: In vitro selection technique. 5 rounds of selection were performed. RNAs were 
selected for binding to 5HW linked sepharose and competitively eluted with free 5HW. Eluted RNA 
was then reverse transcribed and PCR amplified before transcription, after which they were 
subjected to another round of selection. Image courtesy Ely Porter. 
	   15	  
2.2 Results 
Significant elution was detected by round 3 of the selection, and by the 
end of round 5, almost 20% of the RNA could tightly bind 5HW (Figure 7). 
However, further analysis of 
the resultant DNA revealed 
problems with the final 
library. When DNA from 
each of the 5 rounds of 
selection was separated on 
a gel, it became apparent 
that there were deletions of 
about 20-50 nucleotides 
beginning in round 4 of the 
selection (Figure 8). The 
shortened species became 
dominant after round 
5, suggesting that the 
deletions allowed the 
RNA to better survive 
the selection 
pressure.  
Reverse 
transcriptase is the 
most likely culprit for 
such deletions, given 
that SuperScript III is 
derived from a viral 
RT, M-MLV (Moloney 
Murine Leukemia 
Virus Reverse 
	   	  	  	  
Figure 7: RNA elution after each round of 
selection. RNA elution was calculated as a 
percentage of total RNA. Significant elution was 
detected after the third round of selection, and 
rounds 4 and 5 resulted in almost 20% elution.	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Figure 8: DNA amplification of each selection round. 
Gel electrophoresis of DNA from each round in the 
selection demonstrates large deletions of 20-50 
nucleotides between rounds 3 and 5 (visible in the main 
product band). Additionally, many longer products are 
present. Both of these errors can be attributed the reverse 
transcriptase, which is derived from a viral RT. 
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Transcriptase). Viruses often favor error-prone polymerases in order to rapidly 
increase their genetic diversity. SuperScript III is not well equipped to proceed 
through structured RNAs with high fidelity. Because our selection began with a 
structured library, the RT likely introduced deletions. These errors propagated 
because the RT most efficiently replicated less-structured RNA variants.  
Additionally, RT is known to strand-switch from the 5’ end of an RNA to 
the 3’ end of a new RNA without releasing the nascent DNA (Luo, 1990). This 
accounts for the longer species visible in Figure 8. A size selection was 
performed after each round of transcription, preventing the longer species from 
propagating through the selection. However, smaller changes in product length 
	  
Figure 9: Phylogenetic tree of round 7 sequences. Ely’s selection was analyzed 
after round 7; three main families were represented. Families A and C contained 
deletions destroying the tertiary architecture of the original purine aptamer sequence 
(labeled here “xpt”), but family B maintained the tertiary architecture of the purine 
riboswitch. Thus, family B was selected for further characterization. Secondary 
structures are predicted by minimum free energy modeling. 
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(such as the 20-50 nucleotide deletion) were not detected in the size selection 
step, and could thus proliferate. Further experiments by other Batey lab members 
will investigate the potential use of non-viral RT polymerases to decrease error in 
any future selections. 
Despite the problems I faced in my selection, Ely was successfully able to 
complete his selection from the same starting library through 7 rounds, including 
counter-selections in rounds 6 and 7 against related ligand L-tryptophan. 
Phylogenetic analysis of round 7 sequences resulted in 3 aptamer families 
(Figure 9).  
Families A and C both had two single-nucleotide deletions that destroyed 
the tertiary interactions of the original purine riboswitch. Family A deletions 
occurred in the capping loops of P2 and P3, destroying the tertiary loop-loop 
interaction. These single-nucleotide deletions may again be signatures of the 
reverse transcriptase.  Alternately, family C deletions allowed the RNA to adopt a 
completely different secondary structure (as predicted by minimum free energy 
models). The RNA is predicted to form a single long hairpin with several loosely 
structured regions. Once more, the RT would likely favor this structure and 
propagate these deletions through the pool.  
Family B aptamers, however, maintained the sequence arrangement of 
the original purine riboswitch in non-randomized sections while adopting an 
entirely unique sequence in randomized regions. Additionally, Ely was able to 
demonstrate via isothermal titration calorimetry (ITC) that the family B sequence 
bound 5HW with high affinity and specificity: The family B aptamer bound 5HW 
with a KD of 3.9 ± 0.1 µM, while it bound L-tryptophan with a KD of 280 ± 30 µM. 
Thus, the family B aptamers were selected for further characterization. 
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3. Crystallization and Structure Determination of Family B Aptamer 
Since family B emerged as the best aptamer from the selection, its crystal 
structure was determined in order to demonstrate that it maintained the tertiary 
architecture of the purine riboswitch in non-randomized regions, and to 
understand its ability to recognize 5HW with a high affinity and specificity. 
3.1 Crystallization 
To determine the structure 
of the family B aptamer, four 
different variants of family B were 
constructed and tested for their 
ability to crystallize. Each RNA was 
constant in both the randomized 
regions and the P2 and P3 helices, 
while the P1 stem length was 
altered to lengths 5, 6, 7, and 8 
base pairs (Figure 10). Sequence 
of the P1 stem was chosen based 
on previous successes in the Batey 
lab in crystallizing the purine 
riboswitch (Batey et al., 2004). The 
sequences were then PCR 
amplified, in vitro transcribed, and 
purified via 8 or 12% denaturing 
polyacrylamide gel. The RNA was concentrated in Millipore 10,000 MWCO 
concentrators and exchanged into .5X Tris-EDTA buffer.  
The standard hanging-drop method was used to crystallize the RNA. In 
hanging drop crystallography, a drop containing roughly equal parts RNA in 
buffer and a mother liquor solution is suspended over a solution of pure mother 
liquor in a sealed container. The mother liquor contains solvents in which RNA is 
generally insoluble and/or high salt concentrations. Vapor diffusion causes water 
to move out of the drop and mother liquor to move into the drop such that the 
	  
Figure 10: Family B crystallization 
constructs. Four sequences were 
designed and tested for crystallization. 
Each sequence was invariant in P2, P3, 
and the randomized regions, but had a 
different P1 stem length. P1-6 
crystallized most readily. 
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vapor pressure of the drop and the mother liquor below eventually equalize. This 
slowly decreases the solubility of the RNA, allowing crystallization to occur. 
Crystallization of the four constructs was first tested using kits obtained 
from Hampton Research, including the Nucleic Acid Mini Screen, the Natrix 1 
and 2 Screens, and the Crystal Screen. Crystal trays were set up as directed by 
protocols contained in each kit using RNA solutions 2 mM in 5HW and 400 µM in 
RNA in .5X Tris-EDTA buffer. The RNA with P1 stem length 6 was observed to 
generate robust crystals in Nucleic Acid Mini Screen condition 3 (Figure 11).  
Conditions were further optimized such that diffraction-quality crystals 
were reliably formed (Figure 11). The best crystals were produced in 8-14% 
MPD, 40 mM sodium cacodylate pH 5.5, 4 mM magnesium chloride, 12 mM 
sodium chloride, 80 mM potassium chloride, and either 4 – 9 mM cobalt 
hexammine or 1 – 11 mM iridium hexammine. Each drop contained 2.0 µL RNA 
solution and 3.5 µL mother liquor, and crystals were generally fully formed after 2 
– 3 days at 22 °C. Additionally, a micro-seeding technique was employed to 
encourage nucleation: Drops with lower-quality crystals were harvested, and 
crystals were crushed under a microscope before transfer to a microcentrifuge 
tube. Cat whiskers were dipped into the solution and streaked across each drop 
A      B 
	   	  
Figure 11: Nucleic Acid Mini Screen condition 3, P1-6 RNA. A) P1-6 readily 
crystallized in condition 3 from the Nucleic Acid Mini Screen. B) The mother liquor 
conditions were optimized to obtain diffraction-quality crystals. 
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during assembly of a new tray, depositing very small amounts of crystalline RNA. 
This provides nucleation points on which new, high-quality crystals can 
assemble. 
Crystals were cryoprotected by 
the addition 10 µL mother liquor to the 
crystal drop. The crystals were then 
mounted in a nylon loop and screened 
on the home source x-ray beam: a 
Rigaku MSC x-ray diffractometer with 
a rotating copper anode. Crystals 
diffracted to a resolution of 2.0 Å and 
fit into the C2 monoclinic space group 
in the presence of both iridium 
hexammine and cobalt hexammine 
(Figure 12). The structure was solved 
using the single isomorphous 
replacement with anomalous signal 
(SIRAS) method, where cobalt 
hexammine was replaced with iridium hexammine, which in turn has a small 
amount of anomalous scattering at the copper anode wavelength. Rwork and Rfree 
were determined to be 0.22 and 0.26, respectively, which fall under the 
acceptable limits. 
 
3.2 Structure 
The structure of the family B aptamer displayed remarkable similarity to 
the original purine riboswitch (Figure 13). In particular, the loop-loop interaction 
between P2 and P3 is almost identical, with a root-mean-square difference 
(RMSD) of 1.1 Å as calculated by PyMOL, a free molecular modeling software. 
The P1 stems overlay with an RMSD of 0.9 Å, while the binding pockets overlay 
with a relatively large RMSD of 11 Å, indicating essentially no relationship. 
Overall, the molecules have an RMSD of 2.6 Å, reflecting the structural similarity 
	  
Figure 12: Typical diffraction pattern 
of family B P1-6 crystals. The crystals 
diffract to a resolution of ~2.0 Å. The 
image shown corresponds to an RNA co-
crystallized with iridium hexammine. 
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of the RNAs in non-randomized regions and the almost complete rearrangement 
of the binding pocket. 
The binding of 5HW is mediated by U13 in the junction between the P1 
and P2 helices (J1/2), as well as residues U34, A36, and A37 in the junction 
between the P2 and P3 helices (J2/3) (Figure 14). The RNA recognizes all of the 
major functional groups of 5HW, which likely contributes to its high affinity and 
specificity. The amino group of 5HW forms hydrogen bonds with both the 2’-
hydroxyl on the ribose ring of U13 and the endocyclic amine on A37. The 2-
carbonyl group of U34 forms a hydrogen bond with the endocyclic amine on 
5HW. The 5HW ring system forms pi stacking interactions with A36 and A37. 
Additionally, the exocyclic 5-hydroxyl group in 5HW makes a backbone contact to 
the phosphate group of U39. The RNA is selective for 5HW over tryptophan, and 
A     B 
	   	  
Figure 13: Crystal structure of the family B riboswitch. A) Family B structure, 
with randomized regions in cyan, 5HW in orange, and the P1 helix in green. B) 
Family B structure overlaid with the original purine structure. Root-mean square 
deviations for the P2-P3 interaction (blue), randomized region (red), and P1 helix 
(green) were calculated independently of the rest of the structure. Total RMSD 
(black) was calculated to be 2.6 Å. 
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this backbone contact is likely responsible. One of the oxygen atoms in the 
carboxyl group of 5HW forms a hydrogen bond with the exocyclic amino group 
A      B 
	  
Figure 14: 5HW binding in the family B aptamer. A) Secondary structure of the 
family B riboswitch, with U13, U34, A37, A37, and U39 shown in red. These residues 
are primarily responsible for 5HW binding. B) Tertiary structure of the family B ligand-
binding pocket. All of the major functional groups of the 5HW are recognized through 
hydrogen bonding, with the exception of the carboxyl terminus, where the linker stem 
would have been located. Additionally, 5HW forms pi-stacking interactions with both 
A36 and A37. 
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Figure 15: T-loop motif is exploited by 5HW. A) The T-loop motif in the 5HW-
binding pocket of family B allows 5HW to pi-stack between A36 and A37. B) The T-
loop motif is a common RNA structural element (Krasilnikov & Mondragon, 2003). 
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on A37, while the other oxygen atom is noticeably unrecognized. The 
unrecognized oxygen atom is where the linker stem to the sepharose bead would 
have been bound in the selection. 
The main binding region from U33 to A37 forms the familiar T-loop motif 
(Krasilnikov & Mondragon, 2003) (Figure 15). The T-loop motif is a common RNA 
formation found in many RNA structures. It was first identified in tRNA 
(Krasilnikov & Mondragon, 2003). U33 and A37 are base-paired, while U34, G35, 
and A36 form a sharp turn. 5HW exploits base stacking between A36 and A37, 
binding between the two bases. Overall, the structure corroborates previous 
evidence that the aptamer can maintain the overall tertiary architecture of the 
purine riboswitch while selectively binding 5HW. 
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4. Current Research: Crystallization of the Family C Aptamer 
Although family B was the only aptamer that maintained the tertiary 
architecture of the purine riboswitch, the family C aptamer was also of interest. 
Of particular note was that part of the predicted secondary structure matched the 
consensus sequence of a previously characterized tryptophan-binding aptamer 
that was derived via a completely randomized selection (Majerfeld et al., 2010) 
(Figure 16). Upon further characterization of family C, Ely was able to determine 
that it was, indeed, non-selective for 5HW over tryptophan, and that its KD was 
similar to the previously described tryptophan aptamer. It bound 5HW with a KD 
of 38 ± 14 µM, while it bound tryptophan with a KD of 20 ± 5 µM, while the 
previous study reported a KD of 15 µM for the tryptophan aptamer, which is within 
error of the obtained KD for the family C aptamer. Thus, the structure is an 
attractive target for crystallization, not only because it can be compared to the 
family B structure, but also because it may help describe how different RNA 
sequences can bind the same ligand with completely different affinities and 
specificities. 
 
	   A     B 
	  
Figure 16: Family C is a previously characterized tryptophan-binding 
aptamer. A) A small area of the family C aptamer matches the consensus 
sequence for a previously characterized tryptophan aptamer B) described by 
Majerfeld et al., 2010. 
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4.1 Crystallizing a Small Hairpin 
The family C aptamer, hereupon referred to as the tryptophan aptamer, 
presents many difficulties for crystallization. Firstly, the structure of a small 
hairpin can result in folding heterogeneity. A small hairpin is self-complementary, 
so it can readily dimerize into a double helix (Figure 17). Thus, at any given time, 
a part of the RNA population may be in a double helix, while a different part of 
the population may be folded into the single-stranded hairpin. Pool heterogeneity 
is detrimental to crystal formation because if a double stranded RNA packs into 
the crystal lattice of RNAs that are all single-stranded hairpins or vice versa, the 
crystal lattice will be poisoned, and no uniform crystal can form. 
Secondly, even if the RNA folds could be made uniform, double helices 
and small hairpins still face problems in long fiber formation (Figure 17). Helices 
lack nucleotides that can form crystal contacts along their backbones, while most 
of their potential for forming crystal contacts is at the ends of the helices. Thus, 
the helices can easily stack one on top of another other utilizing end-to-end 
A       B 
	  
Figure 17: Difficulties in crystallizing small hairpins. A) Small hairpins are 
self-complementary and can thus form double helices. Folding heterogeneity 
can lead to lattice poisoning. B) Helices can stack end-on-end to form long 
fibers, but they have few crystal contacts along their edges. Thus, the unit cell 
can be composed of non-repeating units. 
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crystal contacts to form long fibers. However, each fiber cannot communicate 
effectively with 
neighboring fibers 
because of the lack of 
crystal contacts. As a 
result, fibers will be 
oriented against each 
other randomly, and 
although a crystal 
lattice can form and 
electron density may 
even be calculated, 
the electron density 
will show only a long 
barrel of 
homogeneous 
electron density, as 
each fiber is not oriented uniformly in the unit cell. 
Thus, in order to crystallize the hairpin, the S-adenosylmethionine-I (SAM-
I) riboswitch was used as a scaffold to which the tryptophan aptamer was 
appended. Although previous studies have utilized protein/RNA hybrid scaffolds 
to aid in crystallization (Ferré-D’Amaré, 2010), no study to-date has used a 
riboswitch as a scaffold for crystallization. Members of the Batey laboratory 
previously solved the SAM-I riboswitch structure to high resolution (Montagne et 
al., 2006). The structure has two helices, P3 and P4, which extend into space 
(Figure 18), and it was reasoned that the tryptophan aptamer could be affixed 
onto these helices without perturbing the SAM-I structure and allowing for 
tryptophan binding. Since the SAM-I riboswitch is not self-complementary and 
will not form long helix fibers, this approach could solve problems crystallizing the 
small hairpin aptamer. 
 
	  
Figure 18: SAM-I Riboswitch. The P4 (magenta) and 
P3 (yellow) helices extend into space, so it was 
reasoned that they could be elongated without 
perturbing SAM binding (Montange et al., 2009). 
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4.2 Designing SAM-I Tryptophan Fusion Sequences that Bind Tryptophan 
In order to prove that the tryptophan aptamer fused to the SAM-I 
riboswitch bound tryptophan using the same mechanism as the tryptophan 
aptamer alone, ITC was employed. Generally, if an aptamer has the same KD 
and sequence as another aptamer, it can be inferred that the binding mechanism 
is the same. Thus, the KD’s of each fusion construct were measured before 
crystallization was attempted so that any resulting structures would be sure to 
employ the same tryptophan binding mechanism as the free tryptophan aptamer. 
The first sequences constructed were designed as the minimal constructs 
believed to be required for the RNA to maintain SAM binding while introducing 
tryptophan binding (Figure 19). 
Minimal constructs are desirable in 
crystallizations because 
nonessential elements may 
increase the degrees of freedom in 
the structure, which in turn may 
decrease the resolution limit. Thus, 
only two base pairs were added 
between the tryptophan aptamer 
and the last residues critical for 
SAM binding in the P3 and P4 
helices. Because the orientation of 
a capping loop on the tryptophan 
aptamer is not conserved, the 
aptamer was appended in both possible orientations, where the capping loop 
was on opposite ends. These two orientations were termed Trp-L and Trp-R. The 
GAAA capping tetraloop was chosen for its potential to form crystal contacts with 
neighboring molecules. By putting each tryptophan orientation onto each the P3 
and P4 helices respectively, four constructs were designed.  
The constructs were PCR amplified, transcribed, and purified using the 
same protocol described in RNA preparation for family B crystallization. ITC was 
	  
Figure 19: First SAM-tryptophan fusion 
constructs. Constructs minimizing linker length 
between the SAM binding region and the 
tryptophan aptamer were designed. 4 
constructs resulted, where each Trp-R and –L 
were affixed to P3 and P4, respectively. 
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performed under conditions previously employed for measuring the KD of the 
tryptophan aptamer, using a buffer containing 50 mM sodium HEPES pH 7.0, 
250 mM sodium chloride, 5 mM magnesium chloride, and 5 mM calcium chloride 
(Majerfeld et al., 2010). Each construct was measured for tryptophan binding 
using ITC, but none could effectively bind tryptophan in either the presence or 
absence of SAM. Thus, new constructs were created to potentially remedy the 
lack of tryptophan binding. 
The second 
iteration of constructs 
augmented the helix 
length between the 
tryptophan aptamer and 
the SAM-I binding pocket 
from two base pairs to 
four (Figure 20). 
Additionally, the Trp-R 
orientation of the 
tryptophan aptamer was 
not tested to reduce 
iterations required. 
However, an additional 
base pair was added to 
the Trp-L sequence 
between the aptamer and the capping tetraloop to ensure helix stability. Thus, 
two constructs were designed: SAMTrp-L+1 P3+2 (appending the Trp-L aptamer 
orientation with the addition of one base pair to the P3 helix with two additional 
base pairs in the adjoining region) and SAMTrp-L+1 P4+2 (the equivalent design 
appended in the P4 helix instead of the P3 helix).  
Again, these constructs were PCR amplified, transcribed, and purified. 
They were tested for binding via ITC in the same buffer conditions, and 
tryptophan binding was detected. The KD of the SAMTrp-L+1 P3+2 construct was 
	  
Figure 20: SAM-I tryptophan fusion constructs 
with increased helix length. The helix linker 
between the tryptophan aptamer was increased 
from 2 base pairs a minimum of 4 base pairs and a 
maximum of 9 base pairs. Additionally, one base 
pair was added to the end of the Trp-L construct to 
increase helix stability.  
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determined to be 16 ± 2 µM, and the KD of the SAMTrp-L+1 P4+2 construct was 
determined to be 16 ± 1 µM. Both values are within acceptable error of values 
obtained previously for the tryptophan aptamer, which ranged from 12 to 15 µM 
(Majerfeld et al., 2010). Thus, it can be strongly suggested that the tryptophan 
aptamer bound in the same manner in both the free aptamer and the SAM-I 
fusions. Additionally, it was reasoned that mutants with longer linker helix lengths 
between SAM-I and the Trp-L+1 aptamer sequence would also bind tryptophan 
with similar KD’s. Therefore, several SAM-I tryptophan fusion sequences with 
helix linker lengths +2 – +7 were screened for crystallization (Figure 20). 
 
4.3 Crystallizing SAM-I Tryptophan Fusion RNAs 
SAM-I tryptophan fusion constructs using the Trp-L+1 aptamer and helix 
linker lengths +2 – +7 were PCR amplified, transcribed, and purified. Hanging-
drop crystallization was utilized as formerly described. Crystal screens were 
again employed to search for initial mother liquor conditions that could encourage 
crystallization. The Hampton Research Nucleic Acid Mini Screen, Natrix 1 
Screen, Natrix 2 Screen, and Crystal Screen were all tested, in addition to the 
Qiagen Nucleix Suite and PEG II’s Suite for a total of 360 unique mother liquor 
conditions. All screens were used as described in protocols provided by each 
A      B 
	   	  
Figure 21: SAMTrp-L+1 P4+5 crystals. A) Large SAMTrp-L+1 P4+5 crystals 
grow reproducibly when barium chloride is added to the mother liquor. B) 
However, the crystals only diffract to a resolution of ~5.0 Å. 
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company, using RNA solutions 400 µM in RNA, 2 mM in SAM, and 2 mM in 
tryptophan in .5X Tris-EDTA buffer. 
SAMTrp-L+1 P4+5 was able to crystallize in several different Natrix 2 
conditions. Mother liquor conditions were optimized, and the best crystals were 
observed in 1 mM cobalt hexammine, 9% ethanol, 50 mM sodium cacodylate pH 
6.5, 45 – 55 mM magnesium acetate, and 100 – 110 mM barium chloride. 
Crystals were cryoprotected with a 10 µL of a solution isotonic to the above 
mother liquor with an additional 15% 2-methyl-2,4-pentanediol (MPD) and flash 
frozen in liquid nitrogen. Several crystals were screened, but even the best 
crystals could not achieve below 5.0 Å resolution (Figure 21). Generally, around 
3.5 Å is the maximum resolution limit required to accurately determine a 
structure. Thus, it became apparent that the structure could not be solved to high 
resolution with the SAMTrp-L+1 P4+5 construct. 
Currently, a new set of mutations to the SAMTrp-L+1 P4+5 construct is 
being investigated. Three mutations were chosen for their success in increasing 
resolution on the original SAM-I riboswitch: an A14 deletion, a U34 to C mutation, 
and an A94 to G mutation (Montagne et al., 2009). The mutations occur on 
residues that are oriented out from the riboswitch such that they can potentially 
form crystal contacts with neighboring RNA molecules (Figure 22). Three 
constructs containing one mutation each were created and are presently being 
tested for a potential increase in resolution.
A       B 
	  
Figure 22: SAMTrp-L+1 P4+5 mutants. A) Three different mutants will be 
screened for their ability to form high-resolution crystals. B) The mutations 
occur on residues extending from the surface of the RNA, so they may affect 
crystal contacts with neighboring RNA molecules (Montagne et al., 2009). 
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5. Discussion 
Although riboswitches are attractive targets for synthetic biologists, past 
research has generally only been able to broadly utilize natural riboswitch 
aptamer domains to create a response. This study has presented a possible 
mechanism by which an aptamer might retain regulatory capabilities while 
recognizing a novel ligand. The purine riboswitch was successfully reselected for 
binding to 5HW. The crystal structure of the new, 5HW-sensing aptamer 
demonstrated the ability of an RNA to bind a novel ligand while maintaining 
tertiary architectures necessary for gene regulation. This approach may prove 
effective in creating a synthetic riboswitch system, which Ely is currently 
attempting with the family B aptamer. If successful, synthetic riboswitches could 
be used for a range of applications, from ligand sensing to feedback regulation in 
fully synthetic pathways. 
Furthermore, determining the structure of the tryptophan aptamer will 
increase our understanding of how different RNAs can bind the same ligand. The 
tryptophan aptamer has a different binding affinity and specificity as compared to 
the family B aptamer, despite arising from the same selection and binding the 
same ligand. This suggests that it will likely employ a completely different binding 
mechanism as compared to the family B aptamer. Investigating these different 
binding mechanisms may provide insight into RNA-ligand interactions. In 
addition, if successful, the method employed to crystallize the small hairpin 
tryptophan aptamer will increase our toolbox for determining the structure of 
small, difficult to crystallize RNAs. Thus, the structure of the tryptophan aptamer 
will not only deepen our understanding of RNA ligand recognition, but it will 
present a new tool for RNA crystallographers to potentially crystallize difficult 
RNAs. 
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6. Appendices 
Oligomer Sequences  
Construct Oligomers 
Randomized 
purine 
library 
xpt-pbuX scaffold (bold denotes the first transcribed nucleotide): 
GCGCGCGAATTCTAATACGACTCACTATAGGACTTCGGTCCAAGCTAATGCA
CTCNNNNNNNCGCGTGGATATGGCACGCANNNNNNNNNNGGGCACCGTAA
ATGTCCNNNNNNGGGTGCATTAGCAAAATCGGGCTTCGGTCCGGTTC 
T7 Site Appending Primer xpt: 
GCGCGCGAATTCTAATACGACTCACTATAGGACTTCGGTCCAAGCTAATGCA
CTC 
RT-PCR Primer xpt: 
5’-GAACCGGACCGAAGCCCG 
 
Construct Oligomers 
x17 P1-5 
x17p1-5 gene: 
GCGCGCGAATTCTAATACGACTCACTATAGGATCTGATGATCGCGTGGATATGG
CACGCATTGAATTGTTGGACACCGTAAATGTCCTAACACGGTCC 
5’ x17p1-5 Gen: 
GCGCGCGAATTCTAATACGACTCACTATAGGATCTGATGATCGCGTGG 
3’ x17p1-5m: mUmGGACCGTGTTAGGACATTTACGG 
x17 P1-6 
x17p1-6 gene: 
GCGCGCGAATTCTAATACGACTCACTATAGGACACTGATGATCGCGTGGATATG
GCACGCATTGAATTGTTGGACACCGTAAATGTCCTAACACGTGTCC 
5’ x17p1-6 Gen: 
GCGCGCGAATTCTAATACGACTCACTATAGGACACTGATGATCGCGTGG 
3’ x17p1-6m: mUmGGACACGTGTTAGGACATTTACGG 
x17 P1-7 
x17p1-7 gene: 
TAATACGACTCACTATAGGACATCTGATGATCGCGTGGATATGGCACGCATTGA
ATTGTTGGACACCGTAAATGTCCTAACACGGTGTCC 
5’ Gen: GCGCGCGAATTCTAATACGACTCACTATAGG 
3’ x17p1-7: GGACACCGTGTTAGGACATTTACGG 
3‘ x17p1-7m: mUmGGACACCGTGTTAGGACATTTACGG 
x17 P1-8 
x17p1-8 gene: 
GCGCGCGAATTCTAATACGACTCACTATAGGACACACTGATGATCGCGTGGATA
TGGCACGCATTGAATTGTTGGACACCGTAAATGTCCTAACACGTGTGTCC 
5’ x17p1-8 Gen: 
GCGCGCGAATTCTAATACGACTCACTATAGGACACACTGATGATCGCGTGG 
3’ x17p1-8m: mUmGGACACACGTGTTAGGACATTTACGG 
 
Construct Oligomers (If sequence not listed, it is the same oligo as cells above) 
SAMTrp-
R P3 
F T7.SamI.xtal.01: 
GCGCGCGAATTCTAATACGACTCACTATAGGCTTATCAAGAGAGGTGGAG 
R SamI.p2.wt.02: 
GTTGCCGGGTTTCATCGGGCCAGTCCCTCCACCTCTCTTGATAAGC 
F SamI.trpR.p3.03: 
CGATGAAACCCGGCAACCGGACCGGCGGAAACGGACCGCCACGGTGCCAATT
CCTGCAGC 
R SamI.p4.wt.04: mUmGGCTCATCTTTCAACGTTTCCGCTGCAGGAATTGGCAC 
SAMTrp-
L P3 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL.p3.03: 
CGATGAAACCCGGCAACCGGACCGCCACTGAAAAGGACCGGCGGTGCCAATT
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CCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L P4 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.p3.wt.03: CGATGAAACCCGGCAACCGAAAGGTGCCAATTCCTGCAGC 
R SamI.trpL.p4.04:    
mUmGGCTCATCTTTCAACGCCGGTCCTTTTCAGTGGCGGTCCGCTGCAGGAAT
TGGCAC 
SAMTrp-
L P4 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpR.p4.04: 
mUmGGCTCATCTTTCAACGTGGCGGTCCGTTTCCGCCGGTCCGCTGCAGGAAT
TGGCAC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P3+2 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+2.03    
CGATGAAACCCGGCAACCGCGGACCGCCACTGGAAACAGGACCGGCGCGGTG
CCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+2 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+2.04    
mUmGGCTCATCTTTCAGCGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCGCTG
CAGGAATTGGCAC 
SAMTrp-
L+1 P3+3 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+3.03:    
CGATGAAACCCGGCAACACGCGGACCGCCACTGGAAACAGGACCGGCGCGTG
TGCCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+3 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+3.04    
mUmGGCTCATCTTTCAGACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCGTCT
GCAGGAATTGGCAC 
SAMTrp-
L+1 P3+4 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+4.03    
CGATGAAACCCGGCAACTACGCGGACCGCCACTGGAAACAGGACCGGCGCGT
AGTGCCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+4 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+4.04    
mUmGGCTCATCTTTCAGTACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCGTA
CTGCAGGAATTGGCAC 
SAMTrp-
L+1 P3+5 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+5.03    
CGATGAAACCCGGCAACCTACGCGGACCGCCACTGGAAACAGGACCGGCGCG
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TAGGTGCCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+5 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+5.04    
mUmGGCTCATCTTTCAGCTACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCGT
AGCTGCAGGAATTGGCAC 
SAMTrp-
L+1 P3+6 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+6.03    
CGATGAAACCCGGCAACACTACGCGGACCGCCACTGGAAACAGGACCGGCGC
GTAGTGTGCCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+6 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+6.04    
mUmGGCTCATCTTTCAGACTACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCG
TAGTCTGCAGGAATTGGCAC 
SAMTrp-
L+1 P3+7 
F T7.SamI.xtal.01 
R SamI.p2.wt.02 
F SamI.trpL+1.p3+7.03    
CGATGAAACCCGGCAACGACTACGCGGACCGCCACTGGAAACAGGACCGGCG
CGTAGTCGTGCCAATTCCTGCAGC 
R SamI.p4.wt.04 
SAMTrp-
L+1 P4+7 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+7.04    
mUmGGCTCATCTTTCAGGACTACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGC
GTAGTCCTGCAGGAATTGGCAC 
SAMTrp-
L+1 P4+5 
dA14 
F T7.SamI.xtal.01.dA14 
GCGCGCGAATTCTAATACGACTCACTATAGGCTTATCAAGAGGGTGGAG 
R SamI.p2.02.dA14 
GTTGCCGGGTTTCATCGGGCCAGTCCCTCCACCCTCTTGATAAGC 
F SamI.p3.wt.03 
R SamI.trpL+1.p4+5.04     
SAMTrp-
L+1 P4+5 
U34C 
F T7.SamI.xtal.01  
R SamI.p2.02.U34C 
GTTGCCGGGTTTCGTCGGGCCAGTCCCTCCACCTCTCTTGATAAGC 
F SamI.p3.03.U34C.P3wt+1 
CGACGAAACCCGGCAACCAGAAATGGTGCCAATTCCTGCAGC 
R SamI.trpL+1.p4+5.04     
SAMTrp-
L+1 P4+5 
mCm 
F T7.SamI.xtal.01  
R SamI.p2.wt.02  
F SamI.p3.wt.03 
R SamI.trpL+1.p4+5.04.mCm 
mCmGGCTCATCTTTCAGCTACGCGCCGGTCCTGTTTCCAGTGGCGGTCCGCGT
AGCTGCAGGAATTGGCAC 
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